µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© Hx;ij?
.Q'/e>0
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© ?f1PQ
1¡¢Co-stimulators (or co-stimulating molecules) mNcoR^(VN
2¡¢NK-kB o
m 3$=
3¡¢Immunoglobulin superfamily O6rrv,+_L
4¡¢antigen-presenting cell (APC) rEI]{?eoF
5¡¢death domain !]bXHT&!R
6¡¢CCR and CXCR D>& ;K{!
7¡¢Lectin (or mitogen) eF8!}|*N
8¡¢Clusters of differentiation, CD) %(4G[R[
9¡¢B7 family tT7< V{i4
10¡¢Cytotoxic T lymphocyte, CTL) <0[{Tn
11¡¢IL-15 and IL-15 receptor (IL-15R) *SkUkqP9z
12¡¢MHC restriction '&L ;y
13¡¢Affinity-chromatography Y.$InQ gL
14¡¢Cyctosprin A, CsA ]h (TZu
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) [BS3y`c
"cerg?ix
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© Ks&~VU
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 z-G|EAON"/
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ ?p{xt$<p
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ i<D}"h|
I\R5Cb<p
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© $)|
l#'r
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ e_J_rx
ѪҺ²¡Ñ§×¨Òµ£º +Ux)m4}j
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿